Ilan Y
Liver Unit, Department of Medicine, Hebrew University, Hadassah Medical Center, Jerusalem, Israel.
Aliment Pharmacol Ther. 2007 Nov 15;26(10):1293-302. doi: 10.1111/j.1365-2036.2007.03519.x. Epub 2007 Sep 15.
Hepatologists have long sought to develop a test for assessing liver function, but this aim has been stalled by the complexity of the liver and its diverse functions. Results of metabolic tests, including breath tests, correlate with clinical and histological parameters of patients with liver disorders; however, these tests tend to be cumbersome and impractical for everyday use. The recent development of a real-time, point-of-care liver function breath test has made it straightforward to assess the metabolic function of the liver.
To review the available data on the use of breath tests for assessing liver reserve in various conditions and their application in various clinical hepatology settings.
The (13)C-methacetin breath test enables accurate follow-up of patients with acute or chronic liver damage, where overall hepatic function is significantly suppressed by known causes of liver disorders, including acute, sub-acute or chronic conditions. The metabolic breath test can detect both gradual and spontaneous improvements in liver function and the effects of treatment.
Breath testing that provides continuous quantification of methacetin metabolism may be a sensitive tool for the diagnosis and follow-up of patients with liver disorders.
长期以来,肝病学家一直致力于开发一种评估肝功能的检测方法,但由于肝脏的复杂性及其多种功能,这一目标一直停滞不前。包括呼气试验在内的代谢检测结果与肝病患者的临床和组织学参数相关;然而,这些检测对于日常使用来说往往繁琐且不实用。实时、即时检测肝功能的呼气试验的最新进展使得评估肝脏代谢功能变得简单直接。
回顾关于呼气试验在各种情况下评估肝脏储备功能的现有数据及其在各种临床肝病环境中的应用。
(13)C-美沙西汀呼气试验能够对急性或慢性肝损伤患者进行准确的随访,在这些患者中,整体肝功能因包括急性、亚急性或慢性疾病在内的已知肝脏疾病病因而受到显著抑制。代谢呼气试验可以检测肝功能的逐渐和自发改善以及治疗效果。
提供美沙西汀代谢连续定量的呼气试验可能是肝病患者诊断和随访的敏感工具。